https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/conference-coverage

The Latest

Long-Term Tenofovir Use Associated With Higher Rates of Kidney Problems Img

Long-Term Tenofovir Use Associated With Higher Rates of Kidney Problems

Renal dysfunction was more likely in patients who had taken tenofovir (Truvada, TDF) longer, were older, or also had diabetes or hypertension, according to a study presented at IDWeek 2014.

Asking About Sexual History More Likely to Get HIV-Positive Patients Tested for Syphilis Img

Asking About Sexual History More Likely to Get HIV-Positive Patients Tested for Syphilis

Patients living with HIV who had had their sexual history taken were four times more likely to be tested for syphilis than those who had no such history documented, according to a study presented at IDWeek 2014, highlighting the importance of obtaini...

Comparing Older and Younger Patients Starting HIV Treatment Img

Comparing Older and Younger Patients Starting HIV Treatment

There were no apparent differences between older (aged 50 and up) and younger people living with HIV who initiated antiretroviral treatment in terms of the CD4 and virologic responses; however, blood chemistry and metabolic complications did differ, ...

Does Timing of Flu Vaccination Affect Immunity for HIV-Positive Patients? Img

Does Timing of Flu Vaccination Affect Immunity for HIV-Positive Patients?

More HIV-positive patients who were vaccinated against influenza early in the season got the flu compared to those vaccinated after mid-November, according to a study at IDWeek 2014, raising questions about whether timing of vaccination matters.

Significantly Less BMD Loss With HIV Therapy That Doesn't Contain Tenofovir/Emtricitabine Img

Significantly Less BMD Loss With HIV Therapy That Doesn't Contain Tenofovir/Emtricitabine

Raltegravir was associated with significantly less bone mineral density (BMD) loss in the hip and lumbar spine than was tenofovir/emtricitabine when used as part of a first-line antiretroviral therapy regimen that contained darunavir boosted with rit...

Cardiovascular Disease Risk Missed in Many HIV-Positive Veterans Despite Better Risk-Assessment Tool Img

Cardiovascular Disease Risk Missed in Many HIV-Positive Veterans Despite Better Risk-Assessment Tool

The 2013 ACC/AHA PCE score is found to be a better predictor of cardiovascular disease than the Framingham risk score, but it still failed to identify many HIV-positive U.S. veterans who subsequently had a cardiovascular event, according to a retrosp...

Preventing and Treating HIV-Associated Bone Disease Img

Preventing and Treating HIV-Associated Bone Disease

Given the elevated risk of osteoporosis in people living with HIV -- especially in men over 50 and postmenopausal women -- "clinicians need to be aware of optimal screening and management of bone disease," according to Todd T. Brown, M.D., Ph.D., of ...

Cobicistat Safe for HIV-Positive Patients With Mild to Moderate Renal Impairment Img

Cobicistat Safe for HIV-Positive Patients With Mild to Moderate Renal Impairment

Study finds cobicistat-containing regimens are effective and well-tolerated by HIV-infected patients with mild to moderate renal impairment.

HOPE Act May Not Help People Living With HIV in Need of Organ Transplants Img

HOPE Act May Not Help People Living With HIV in Need of Organ Transplants

The goal of the U.S. HOPE Act is to develop research protocols and criteria to establish whether and how organ transplant policies should change, but it might not actually lead to a significant increase in the availability of high-quality organs for ...

Prevalence of Cancer-Causing HPV High Among Women Living With HIV Img

Prevalence of Cancer-Causing HPV High Among Women Living With HIV

A high prevalence of oncogenic human papillomavirus (HPV) was found in both the anus and the cervix of women living with HIV -- though the prevalence was highest in the anal canal, according to a multicenter French study.